rs149694033

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_033305.3(VPS13A):​c.5884C>T​(p.Arg1962Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00495 in 1,613,306 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1962H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0039 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 24 hom. )

Consequence

VPS13A
NM_033305.3 missense

Scores

1
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:13

Conservation

PhyloP100: 1.13

Publications

8 publications found
Variant links:
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
  • chorea-acanthocytosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033305.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0094463825).
BP6
Variant 9-77323120-C-T is Benign according to our data. Variant chr9-77323120-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 367395.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00392 (597/152160) while in subpopulation NFE AF = 0.00606 (412/67958). AF 95% confidence interval is 0.00558. There are 3 homozygotes in GnomAd4. There are 285 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033305.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
NM_033305.3
MANE Select
c.5884C>Tp.Arg1962Cys
missense
Exon 45 of 72NP_150648.2Q96RL7-1
VPS13A
NM_001018037.2
c.5767C>Tp.Arg1923Cys
missense
Exon 44 of 71NP_001018047.1Q96RL7-3
VPS13A
NM_015186.4
c.5884C>Tp.Arg1962Cys
missense
Exon 45 of 69NP_056001.1Q96RL7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13A
ENST00000360280.8
TSL:1 MANE Select
c.5884C>Tp.Arg1962Cys
missense
Exon 45 of 72ENSP00000353422.3Q96RL7-1
VPS13A
ENST00000376636.7
TSL:1
c.5767C>Tp.Arg1923Cys
missense
Exon 44 of 71ENSP00000365823.3Q96RL7-3
VPS13A
ENST00000419472.1
TSL:1
c.640C>Tp.Arg214Cys
missense
Exon 5 of 7ENSP00000414410.1H0Y7P8

Frequencies

GnomAD3 genomes
AF:
0.00393
AC:
598
AN:
152042
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00564
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00302
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00606
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00362
AC:
907
AN:
250868
AF XY:
0.00358
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00386
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00301
Gnomad NFE exome
AF:
0.00547
Gnomad OTH exome
AF:
0.00524
GnomAD4 exome
AF:
0.00506
AC:
7394
AN:
1461146
Hom.:
24
Cov.:
30
AF XY:
0.00491
AC XY:
3566
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.000957
AC:
32
AN:
33446
American (AMR)
AF:
0.00379
AC:
169
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.00149
AC:
39
AN:
26116
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39652
South Asian (SAS)
AF:
0.000916
AC:
79
AN:
86240
European-Finnish (FIN)
AF:
0.00300
AC:
160
AN:
53388
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5764
European-Non Finnish (NFE)
AF:
0.00593
AC:
6590
AN:
1111532
Other (OTH)
AF:
0.00509
AC:
307
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
344
688
1032
1376
1720
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00392
AC:
597
AN:
152160
Hom.:
3
Cov.:
32
AF XY:
0.00383
AC XY:
285
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.000963
AC:
40
AN:
41536
American (AMR)
AF:
0.00563
AC:
86
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00302
AC:
32
AN:
10598
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00606
AC:
412
AN:
67958
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00504
Hom.:
5
Bravo
AF:
0.00373
Asia WGS
AF:
0.000578
AC:
2
AN:
3476
EpiCase
AF:
0.00682
EpiControl
AF:
0.00723

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not provided (7)
-
2
4
Chorea-acanthocytosis (6)
-
-
1
not specified (1)
-
-
1
VPS13A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
D
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.058
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.94
D
MetaRNN
Benign
0.0094
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
1.1
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Benign
0.059
Sift
Benign
0.032
D
Sift4G
Benign
0.17
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.20
gMVP
0.68
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs149694033;
hg19: chr9-79938036;
COSMIC: COSV100652533;
COSMIC: COSV100652533;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.